Placenta Accreta&Its Complications in Placenta Previa Cases

November 13, 2015 updated by: suzy abdelaziz Abdelhamid, Kasr El Aini Hospital

Incidence of Placenta Accreta & it's Complications in Cases of Previous Cesarean With Placenta Previa Anterior

Cases of previous cesarean with placenta previa anterior underwent cesarean section. Placenta accreta is diagnosed during cesarean section &confirmed by pathology. All complications are monitored in cases with placenta accreta and without.

Study Overview

Status

Unknown

Conditions

Detailed Description

100 cases of gestational age 30 weeks or more with placenta previa anterior with previous one or more cesarean section will be enrolled. History,examination &routine investigations will be taken. Colour doppler will be done to diagnose cases with suspected placenta accreta. Pre & postoperative Hb concentration will be taken. Cases with nonseparation of the placenta will be diagnosed as accreta & confirmed by pathology. Operative time & complications like bladder or intestinal injury will be noted. All data will be analyzed.

Study Type

Observational

Enrollment (Anticipated)

100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Pregnant with gestational age more than 30 weeks with previous one or more cesarean section with placenta previa anterior

Description

Inclusion Criteria:

  • all pregnant women more than 30 weeks with previous one or more cesarean section with placenta previa anterior

Exclusion Criteria:

  • pregnant with unscarred uterus
  • scars other than cesarean section

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patients with placenta accreta.
Time Frame: 3 months
3 months
Number of patients with bladder injury.
Time Frame: 3 months
3 months
Number of patients with intestinal injury.
Time Frame: 3 months
3 months
Number of patients with cesarean hysterectomy.
Time Frame: 3 months
3 months
Number of deaths.
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kasr El Aini Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (ANTICIPATED)

March 1, 2016

Study Completion (ANTICIPATED)

March 1, 2016

Study Registration Dates

First Submitted

November 7, 2015

First Submitted That Met QC Criteria

November 13, 2015

First Posted (ESTIMATE)

November 17, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

November 17, 2015

Last Update Submitted That Met QC Criteria

November 13, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Obgyn. . .

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Placenta Accreta in Placenta Previa Anterior

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe